|Day Low/High||96.72 / 100.22|
|52 Wk Low/High||94.38 / 136.48|
Top picks in the fast-growing medical products market.
Warren Buffett's big bet on kidney dialysis provider DaVita may finally be primed to start paying off, albeit after five frustrating years of negative returns.
The options market is currently pricing an expected move in DaVita stock just below 6% by Friday of this week.
Shares were down 8% Thursday.
The market action is shifting as buy-the-dips is no longer the default trader action.
Mark Bertolini's stock options total in the hundreds of millions of dollars.
Here's what you need to know as Wall Street heads into midday trading.
Using a "buy-write combination" could pay off for this slow performing stock.
'Rocket Stocks' is our list of companies with short-term gain catalysts and longer-term growth potential.
Bad news weighs on health care company's stock, which offers an opportunity.
A 50% retracement to around the $68 area on DVA seems likely.
Keep an eye on these three to see if they can follow through on Friday's breakouts.